Dijana P.
- Country
- Croatia
- Department
- HR10007
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Long‑Term Safety of Repeated Subcutaneous ADX‑324, a Prekallikrein‑Targeting siRNA, in Adults With Hereditary Angioedema: Phase 3 Extension Study
Data & Insights
Has run more than one trial at 101 of 230 partner sites.
Specializations
Autoimmune Disorders
This investigator specializes in treating complex systemic autoimmune conditions, with particular emphasis on systemic lupus erythematosus and lupus nephritis. Their research explores innovative therapeutic approaches for managing these challenging conditions.
- SLE Management
- Lupus Nephritis Treatment
- Disease Activity Assessment
The investigator's work includes evaluation of novel compounds for treating lupus manifestations.
Rheumatic Conditions
The investigator focuses on treating Sjögren's Syndrome and its systemic manifestations, particularly studying therapeutic interventions for patients with moderate to severe disease activity.
- Systemic Disease Management
- Long-term Treatment Approaches
- Disease Activity Monitoring
Their work encompasses comprehensive evaluation of treatment efficacy in systemic manifestations.
Inflammatory Arthritis
The investigator has significant expertise in treating psoriatic arthritis, focusing on reducing disease symptoms and improving patient outcomes through targeted therapeutic approaches.
- PsA Treatment Optimization
- Symptom Management
- Disease Activity Assessment
Their research includes evaluation of novel treatments for active psoriatic arthritis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.